IP Osgoode is an independent voice that explores legal governance issues at the intersection of intellectual property (IP) and technology. The program’s researchers, collaborators, and students actively engage in some of the most important and cutting-edge IP law and technology related research and policy discussions of today.
Commentary and analysis on the latest developments in intellectual property, technology and privacy, featuring curated contributions from students, scholars, and experts within the Osgoode community.
In this age where the advancement and innovation of science and technology is heavily sought after as an ideal, and the “progress of science” specifically promoted by the US Constitution, it seems altogether inappropriate that Verizon was able to sue Vonage for damages amounting to US$58 million for infringing 3 of its patents that […]
The past two decades have been marked by extreme technological advances.¦lt;br /> The internet has opened many doors in the way of business transactions, availability of resources and research and most notably a new communication ability and efficiency. In 2003, Linden Research Inc. launched Second Life which is one of the newest developments in […]
The ever-growing world of online social networking is a creature with many faces. From organizing events to finding companionship, programs such as Facebook offer something for everybody. But as the recent fiasco involving Canada Border Services Agency (CBSA) officers shows, beneath the superficial glitter lies a dark and potentially dangerous side to the technology. […]
While it may be somewhat premature to criticize the government on their plans to criminalize identity theft, Justice Minister Rob Nicholson’s recent announcement seems to demonstrate the government’s rather narrow appreciation for the scope of the problem. Based on a reading of the press release provided by the Office of the Minister of Justice […]
Am I being naïve? I hope not. I sincerely hope that I am not being naïve believing in the fairness and equity of the law, and believing that the courts are actually being just – especially when they judge in cases involving humanitarian organizations such as the Red Cross. The company Johnson and Johnson, the […]
In 2003, the Tufts Center for the Study of Drug Development ("Tufts") estimated the cost to develop a new drug to be in excess of $850 million.¦lt;br /> Today, that figure is likely well into the billions. Tufts also found that approximately 20% of new drugs that enter clinical testing eventually receive U.S. marketing approval. […]
Editor in Chief: Prof. Carys Craig (ccraig@osgoode.yorku.ca)
Submission inquiries: iposgoode@osgoode.yorku.ca